Clinical Trial Update: Oral Immunotherapy (OIT) for Peanut Allergy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of oral immunotherapy for peanut allergy completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Peanut Hypersensitivity | Phase 2 | Status: COMPLETED | Results posted: 2017-05-15